This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Plummer, M. Articles by Muñoz, N. Search for Related Content PubMed PubMed Citation Articles by Plummer, M. Articles by Muñoz, N.

Helicobacter pylori and Stomach Cancer: A Case-Control Study in Venezuela

International Agency For Research on Cancer, F-69372 Lyon, France [M. P., N. M.]; Cancer Control Center, San Cristobal 5050, Venezuela [J. V., G. L., W. O.]; University Hospital, 86021 Poitiers Cédex, France [J-L. F.]; Department of Gastroenterology, Free University Hospital, NL-1007 MB Amsterdam, the Netherlands [A. S. P.]; Istituto Ricerche Immunobiologiche Siena Research Center, Chiron SpA, 1-53100 Siena, Italy [G. D. G.]; Hospital S. Giovanni Battista di Torino, 1-10126 Turin, Italy [A. P.]; and Tokyo University School of Medicine, Tokyo 143-8541, Japan [K. M.]

The role of Helicobacter pylori infection in gastric cancer was evaluated in a high-risk population in Venezuela using serological assays in a study of 302 cases and 483 neighborhood controls. To investigate the claim that assays for H. pylori should use antigens derived from local strains, four different assays derived from Venezuelan and European strains were used. Prevalence of IgG H. pylori antibodies in controls was very high, with estimates between 72 and 92%. Prevalence was similar in cases and controls. However, cases had lower antibody titers. This effect was observed only in subjects with low pepsinogen (PG) levels PGI/PGII <3.0), which suggested that extensive atrophy in cases causes a loss of H. pylori infection, with a consequent reduction in antibody titer. In addition, advanced cases (stage II or higher) had lower antibody titers than less advanced cases, which indicated that the lower antibody titers in cases may be attributable partially to a diminished immune response. All of the four assays for anti-H. pylori antibodies gave similar results. No evidence was found for the superiority of the assay based on Venezuelan strains. These results are consistent with other case-control studies in high-risk populations and highlight the difficulties of investigating H. pylori infection in retrospective studies.

This article has been cited by other articles:

				L A Anderson, S J Murphy, B T Johnston, R G P Watson, H R Ferguson, K B Bamford, A Ghazy, P McCarron, J McGuigan, J V Reynolds, et al. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study Gut, June 1, 2008; 57(6): 734 - 739. [Abstract] [Full Text] [PDF]

				M. Plummer, L.-J. van Doorn, S. Franceschi, B. Kleter, F. Canzian, J. Vivas, G. Lopez, D. Colin, N. Munoz, and I. Kato Helicobacter pylori Cytotoxin-Associated Genotype and Gastric Precancerous Lesions J Natl Cancer Inst, September 5, 2007; 99(17): 1328 - 1334. [Abstract] [Full Text] [PDF]

				D. Schottenfeld and J. Beebe-Dimmer Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin, March 1, 2006; 56(2): 69 - 83. [Abstract] [Full Text] [PDF]

				T. T. H. Hoang, T.-U. Wheeldon, C. Bengtsson, D. C. Phung, M. Sorberg, and M. Granstrom Enzyme-Linked Immunosorbent Assay for Helicobacter pylori Needs Adjustment for the Population Investigated J. Clin. Microbiol., February 1, 2004; 42(2): 627 - 630. [Abstract] [Full Text] [PDF]

				A. Seydel, E. Tasca, D. Berti, R. Rappuoli, G. Del Giudice, and C. Montecucco Characterization and Immunogenicity of the CagF Protein of the cag Pathogenicity Island of Helicobacter pylori Infect. Immun., November 1, 2002; 70(11): 6468 - 6470. [Abstract] [Full Text] [PDF]